グローバル・HIV-AIDSテスト市場動向(2014-2018)...市場調査レポートについてご紹介

【英文タイトル】Global HIV-AIDS Testing Market 2014-2018

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. HIV and AIDS Overview
05.1.1 Types of HIV
06. Introduction
07. Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis
08. Market Segmentation by Category
08.1 Global HIV-AIDS Testing Market by Category
09. Types of HIV Tests
09.1.1 Antibody Tests
09.1.2 Antigen Tests
09.1.3 PCR Tests
10. Geographical Segmentation
10.1 Global HIV-AIDS Testing Market by Geographical Segmentation
11. Top 20 Countries with HIV Infected Population
12. Buying Criteria
13. Market Growth Drivers
14. Drivers and their Impact
15. Market Challenges
16. Impact of Drivers and Challenges
17. Market Trends
18. Trends and their Impact
19. Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Mergers and Acquisitions
19.2 Market Share Analysis 2013
19.3 Other Prominent Vendors
20. Key Vendor Analysis
20.1 Abbott Laboratories
20.1.1 Key Facts
20.1.2 Business Description
20.1.3 Business Segmentation
20.1.4 Business Strategy
20.1.5 Revenue Segmentation
20.1.6 Revenue Comparison 2012 and 2011
20.1.7 Geographical Segmentation
20.1.8 Key Information
20.1.9 SWOT Analysis
20.1.10 Strengths
20.1.11 Weakness
20.1.12 Opportunities
20.1.13 Threats
20.2 Bio-Rad Laboratories Inc.
20.2.1 Key Facts
20.2.2 Business Description
20.2.3 Business Segmentation
20.2.4 Business Strategy
20.2.5 Revenue Segmentation of Bio-Rad Laboratories Inc.
20.2.6 Revenue Comparison FY2012 and FY2011
20.2.7 Bio-Rad Laboratories Inc. by Geographical Segmentation
20.2.8 Key Information
20.2.9 SWOT Analysis
20.2.10 Strengths
20.2.11 Weakness
20.2.12 Opportunities
20.2.13 Threats
20.3 Hologic Inc.
20.3.1 Key Facts
20.3.2 Business Description
20.3.3 Business Segmentation
20.3.4 Business Strategy
20.3.5 Revenue Segmentation
20.3.6 Revenue Comparison FY2012 and FY2013
20.3.7 Geographical Segmentation
20.3.8 Key Information
20.3.9 SWOT Analysis
20.3.10 Strengths
20.3.11 Weaknesses
20.3.12 Opportunities
20.3.13 Threats
20.4 Ortho-Clinical Diagnostics Inc.
20.4.1 Key Facts
20.4.2 Business Overview
20.4.3 Key Information
20.4.4 SWOT Analysis
20.4.5 Strengths
20.4.6 Weakness
20.4.7 Opportunities
20.4.8 Threats
20.5 Roche Diagnostics
20.5.1 Key Facts
20.5.2 Business Description
20.5.3 Business Segmentation
20.5.4 Revenue Segmentation
20.5.5 Geographical Segmentation
20.5.6 Business Strategy
20.5.7 Key Information
20.5.8 SWOT Analysis
20.5.9 Strengths
20.5.10 Weaknesses
20.5.11 Opportunities
20.5.12 Threats
20.6 Siemens Healthcare Diagnostics Inc.
20.6.1 Key Facts
20.6.2 Business Overview
20.6.3 Key Information
20.6.4 Business Strategy
20.6.5 SWOT Analysis
20.6.6 Strengths
20.6.7 Weaknesses
20.6.8 Opportunities
20.6.9 Threats
21. Other Reports in this Series
Exhibit 1: Market Research Methodology
Exhibit 2: Global HIV-AIDS Testing Market Overview
Exhibit 3: Global HIV-AIDS Testing market 2013-2018 (US$ billion)
Exhibit 4: Global HIV-AIDS Testing Market Segmentation by Category
Exhibit 5: Global HIV-AIDS Testing Market Segmentation by Category 2013
Exhibit 6: Types of HIV Tests
Exhibit 7: Global HIV-AIDS Testing Market by Geographical Segmentation 2013
Exhibit 8: Top 20 HIV Infected Countries with HIV Infected Population 2012
Exhibit 9: Business Segmentation of Abbott Laboratories
Exhibit 10: Revenue Segmentation of Abbott Laboratories 2012
Exhibit 11: Revenue Comparison 2012 and 2011 (US$ million)
Exhibit 12: Abbott Laboratories by Geographical Segmentation 2012
Exhibit 13: Business Segmentation of Bio-Rad Laboratories Inc.
Exhibit 14: Revenue Segmentation of Bio-Rad Laboratories Inc. FY2012
Exhibit 15: Revenue Comparison 2012 and 2011(US$ million)
Exhibit 16: Bio-Rad Laboratories Inc. by Geographical Segmentation 2012
Exhibit 17: Business Segmentation of Hologic Inc.
Exhibit 18: Revenue Segmentation of Hologic Inc. 2013
Exhibit 19: Revenue Comparison FY2012 and FY2013 (US$ million)
Exhibit 20: Hologic Inc. by Geographical Segmentation 2013
Exhibit 21: Business Segmentation of Roche Diagnostics
Exhibit 22: Revenue Segmentation of Roche Diagnostics FY2013
Exhibit 23: Roche Diagnostics by Geographical Segmentation FY2013


【レポート販売概要】

■ タイトル:グローバル・HIV-AIDSテスト市場動向(2014-2018)
■ 英文:Global HIV-AIDS Testing Market 2014-2018
■ 発行日:2014年4月25日
■ 調査会社:Technavio
■ 商品コード:IRTNTR3468
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。